1775 38th Street
Boulder, CO 80301
Bioptix, Inc., through its subsidiary, BiOptix Diagnostics, Inc., develops enhanced Surface Plasmon Resonance (SPR) instruments. BiOptix SPR biosensors shed light on binding parameters that are required for determining whether a biologic or small molecule drug would be efficacious in humans and at what dose a drug should be administered. The company was formerly known as Venaxis, Inc. and changed its name to Bioptix, Inc. in November 2016. Bioptix, Inc. was founded in 2000 and is based in Boulder, Colorado.